In the vaccine area, Synthetic Genomics and the Institute are forming a new vaccine company because we think these tools can affect vaccines to diseases that haven't been possible to date, things where the viruses rapidly evolve, such with rhinovirus.
U području cjepiva Sintethic Genomic i Institut osnivaju novu kompaniju za cjepiva jer mislimo da će ovo oruđe imati utjecaj na cjepiva za bolesti koje ne možemo datirati, kada virusi brzo evoluiraju, ooput rinovirusa.